The glycosylation design space for recombinant lysosomal replacement enzymes produced in CHO cells-Reference-Cited by-同舟云学术

The glycosylation design space for recombinant lysosomal replacement enzymes produced in CHO cells

Published:2019-04-30 Issue:1 Volume:10 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Tian Weihua^ORCID,Ye Zilu,Wang Shengjun,Schulz Morten Alder,Van Coillie Julie^ORCID,Sun Lingbo,Chen Yen-Hsi,Narimatsu Yoshiki,Hansen Lars,Kristensen Claus,Mandel Ulla,Bennett Eric Paul,Jabbarzadeh-Tabrizi Siamak,Schiffmann Raphael,Shen Jin-Song,Vakhrushev Sergey Y.,Clausen Henrik^ORCID,Yang Zhang^ORCID

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/s41467-019-09809-3.pdf

Reference70 articles.

1. Neufeld, E. F. Lysosomal storage diseases. Annu. Rev. Biochem. 60, 257–280 (1991).

2. Futerman, A. H. & van Meer, G. The cell biology of lysosomal storage disorders. Nat. Rev. Mol. Cell. Biol. 5, 554–565 (2004).

3. Parenti, G., Pignata, C., Vajro, P. & Salerno, M. New strategies for the treatment of lysosomal storage diseases (review). Int. J. Mol. Med 31, 11–20 (2013).

4. Desnick, R. J. & Schuchman, E. H. Enzyme replacement therapy for lysosomal diseases: lessons from 20 years of experience and remaining challenges. Annu. Rev. Genom. Hum. Genet. 13, 307–335 (2012).

5. Grubb, J. H., Vogler, C. & Sly, W. S. New strategies for enzyme replacement therapy for lysosomal storage diseases. Rejuvenation Res. 13, 229–236 (2010).

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cell-based glycoengineering of extracellular vesicles through precise genome editing;New Biotechnology;2024-11

2. Proteolytic cleavage of Golgi glycosyltransferases by SPPL3 and other proteases and its implications for cellular glycosylation;Biochimica et Biophysica Acta (BBA) - General Subjects;2024-10

3. Novel genetically glycoengineered human dendritic cell model reveals regulatory roles of α2,6-linked sialic acids in DC activation of CD4+ T cells and response to TNFα;Glycobiology;2024-05-26

4. Pegunigalsidase alfa: a novel, pegylated recombinant alpha-galactosidase enzyme for the treatment of Fabry disease;Frontiers in Genetics;2024-04-12

5. Tuning of CHO secretional machinery improve activity of secreted therapeutic sulfatase 150-fold;Metabolic Engineering;2024-01